Low prevalence of oral leukoplakia in a representative sample of the US population

C Scheifele; PA Reichart; Thomas Dietrich

doi:10.1016/S1368-8375(03)00050-2

Low prevalence of oral leukoplakia in a representative sample of the US population

C Scheifele, PA Reichart, Thomas Dietrich

Dentistry

Research output: Contribution to journal › Article

34 Citations (Scopus)

Abstract

Recent studies reported a tendency towards a lower prevalence of oral leukoplakia (OL), compared with the past. To assess the prevalence of OL in a representative sample of the US population, data from the oral mucosal tissue assessment and some other covariates of 16128 participants in the US National Health and Nutrition Examination Survey (NHANES III) were included. The clinical definition of OL was applied according to the WHO criteria. The weighted prevalence estimates of OL were 0.66+/-0.14% in males, 0.21+/-0.05% in females and 0.42+/-0.08% in total. The age peaks were at 40-49 years in males and at >or=70 years in females. The prevalence estimates were 0.37% for homogeneous OL and 0.06% for non-homogeneous OL. Gingiva (38.8%) and buccal mucosa (30.9%) were the most frequent locations. Compared to previous studies in the USA, a substantial decline of the prevalence of OL was shown.

Original language	English
Pages (from-to)	619-625
Number of pages	7
Journal	Oral Oncology
Volume	39
Issue number	6
DOIs	https://doi.org/10.1016/S1368-8375(03)00050-2
Publication status	Published - 1 Sept 2003

Access to Document

10.1016/S1368-8375(03)00050-2

Cite this

@article{ec45a34b6090485383f7508438e447d0,

title = "Low prevalence of oral leukoplakia in a representative sample of the US population",

abstract = "Recent studies reported a tendency towards a lower prevalence of oral leukoplakia (OL), compared with the past. To assess the prevalence of OL in a representative sample of the US population, data from the oral mucosal tissue assessment and some other covariates of 16128 participants in the US National Health and Nutrition Examination Survey (NHANES III) were included. The clinical definition of OL was applied according to the WHO criteria. The weighted prevalence estimates of OL were 0.66+/-0.14% in males, 0.21+/-0.05% in females and 0.42+/-0.08% in total. The age peaks were at 40-49 years in males and at >or=70 years in females. The prevalence estimates were 0.37% for homogeneous OL and 0.06% for non-homogeneous OL. Gingiva (38.8%) and buccal mucosa (30.9%) were the most frequent locations. Compared to previous studies in the USA, a substantial decline of the prevalence of OL was shown.",

author = "C Scheifele and PA Reichart and Thomas Dietrich",

year = "2003",

month = sep,

day = "1",

doi = "10.1016/S1368-8375(03)00050-2",

language = "English",

volume = "39",

pages = "619--625",

journal = "Oral Oncology",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - Low prevalence of oral leukoplakia in a representative sample of the US population

AU - Scheifele, C

AU - Reichart, PA

AU - Dietrich, Thomas

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Recent studies reported a tendency towards a lower prevalence of oral leukoplakia (OL), compared with the past. To assess the prevalence of OL in a representative sample of the US population, data from the oral mucosal tissue assessment and some other covariates of 16128 participants in the US National Health and Nutrition Examination Survey (NHANES III) were included. The clinical definition of OL was applied according to the WHO criteria. The weighted prevalence estimates of OL were 0.66+/-0.14% in males, 0.21+/-0.05% in females and 0.42+/-0.08% in total. The age peaks were at 40-49 years in males and at >or=70 years in females. The prevalence estimates were 0.37% for homogeneous OL and 0.06% for non-homogeneous OL. Gingiva (38.8%) and buccal mucosa (30.9%) were the most frequent locations. Compared to previous studies in the USA, a substantial decline of the prevalence of OL was shown.

AB - Recent studies reported a tendency towards a lower prevalence of oral leukoplakia (OL), compared with the past. To assess the prevalence of OL in a representative sample of the US population, data from the oral mucosal tissue assessment and some other covariates of 16128 participants in the US National Health and Nutrition Examination Survey (NHANES III) were included. The clinical definition of OL was applied according to the WHO criteria. The weighted prevalence estimates of OL were 0.66+/-0.14% in males, 0.21+/-0.05% in females and 0.42+/-0.08% in total. The age peaks were at 40-49 years in males and at >or=70 years in females. The prevalence estimates were 0.37% for homogeneous OL and 0.06% for non-homogeneous OL. Gingiva (38.8%) and buccal mucosa (30.9%) were the most frequent locations. Compared to previous studies in the USA, a substantial decline of the prevalence of OL was shown.

U2 - 10.1016/S1368-8375(03)00050-2

DO - 10.1016/S1368-8375(03)00050-2

M3 - Article

C2 - 12798406

VL - 39

SP - 619

EP - 625

JO - Oral Oncology

JF - Oral Oncology

IS - 6

ER -

Low prevalence of oral leukoplakia in a representative sample of the US population

Abstract

Access to Document

Fingerprint

Cite this